This lecture discusses the prevalence and financial burden of brain disorders in Europe, focusing on Parkinson's disease as a neurodegenerative disorder. It covers the symptoms, loss of dopamine neurons, environmental and genetic influences, L-DOPA treatments, and brain stimulation therapy.